Altered platelet and coagulation function in moderate-to-severe COVID-19

To reveal if coagulopathies relate to the course of COVID-19, we examined 255 patients with moderate and severe COVID-19, receiving anticoagulants and immunosuppressive drugs. Coagulopathy manifested predominantly as hypercoagulability that correlated directly with systemic inflammation, disease sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Litvinov, Rustem I., Evtugina, Natalia G., Peshkova, Alina D., Safiullina, Svetlana I., Andrianova, Izabella A., Khabirova, Alina I., Nagaswami, Chandrasekaran, Khismatullin, Rafael R., Sannikova, Svetlana S., Weisel, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357814/
https://www.ncbi.nlm.nih.gov/pubmed/34381066
http://dx.doi.org/10.1038/s41598-021-95397-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357814/
https://www.ncbi.nlm.nih.gov/pubmed/34381066
http://dx.doi.org/10.1038/s41598-021-95397-6

Ejemplares similares